People · Operator
Named in public records as an officer, director or promoter · active 2011–2021 · Biotech / Pharma, Pharmaceuticals
| Company | Role | Sector | Stage | Raised · real | Value · est | Tied |
|---|---|---|---|---|---|---|
| Sudo Biosciences, Inc. | — | Biotech / Pharma | Series C | $73.1M | $685.1M | 2021 |
| Silvergate Pharmaceuticals, Inc. | — | Pharmaceuticals | Series B | $30.8M | $156.4M | 2011 |
| Igi Laboratories, Inc | — | Pharmaceuticals | Series A | $16.1M | $61.9M | 2012 |
Bhaskar Chaudhuri at the center, the companies they're named on, and every other operator named alongside them — an interlock map of shared founding teams, boards and funds. Name-matched, so treat as a research lead.
People named alongside Bhaskar Chaudhuri on the same companies — an interlock signal (shared founding team, board, or fund). Name-matched, so verify before acting.
| Operator | Shared | Their companies |
|---|---|---|
| David Johnson | 1 | 35 |
| Patrick Heron | 1 | 11 |
| Joyce Erony | 1 | 8 |
| Charles Moore | 1 | 5 |
| Nathan Every | 1 | 5 |
| James Gale | 1 | 5 |
| Daniel Estes | 1 | 3 |
| Steven J. Morris | 1 | 2 |
| Jane E. Hager | 1 | 2 |
| Shinichiro Fuse | 1 | 2 |
| Michael Hemric | 1 | 2 |
| Joyce B Erony | 1 | 2 |
| LAURA MEDINA | 1 | 2 |
| Bhaskar Chaundhuri | 1 | 1 |
| Robert Mauro | 1 | 1 |
| Bhaskar Chauduri | 1 | 1 |
| Chris Gagliardi | 1 | 1 |
| Barry Barnard | 1 | 1 |
| Edd Fleming | 1 | 1 |
| Mark Parrish | 1 | 1 |
People are matched by normalized name across records; a common name may merge distinct individuals. Treat as a research lead, the same way modeled valuations are directional, not quoted.